Flecainide treats a novel KCNJ2 mutation associated with Andersen-Tawil syndrome

• Hanora A. Van Ert, BSN,
• Elise C. McCune,
• Kate M. Orland, MS,
• Kathleen R. Maginot, MD,
• Nicholas H. Von Bergen, MD,
• Craig T. January, MD, PhD,
• Lee L. Eckhardt, MD, FHRS

Affiliations

Hanora A. Van Ert, BSN

Cellular and Molecular Arrhythmia Research Program, University of Wisconsin-Madison, Madison, Wisconsin

Elise C. McCune

Cellular and Molecular Arrhythmia Research Program, University of Wisconsin-Madison, Madison, Wisconsin

Kate M. Orland, MS

University of Wisconsin-Madison Inherited Arrhythmia Clinic, Division of Cardiovascular Medicine, Department of Medicine, University of Wisconsin-Madison, Madison, Wisconsin

Kathleen R. Maginot, MD

University of Wisconsin-Madison Inherited Arrhythmia Clinic, Division of Cardiovascular Medicine, Department of Medicine, University of Wisconsin-Madison, Madison, Wisconsin

Nicholas H. Von Bergen, MD

University of Wisconsin-Madison Inherited Arrhythmia Clinic, Division of Cardiovascular Medicine, Department of Medicine, University of Wisconsin-Madison, Madison, Wisconsin

Craig T. January, MD, PhD

Cellular and Molecular Arrhythmia Research Program, University of Wisconsin-Madison, Madison, Wisconsin

Lee L. Eckhardt, MD, FHRS

Cellular and Molecular Arrhythmia Research Program, University of Wisconsin-Madison, Madison, Wisconsin